Influence of BRCA1 and BRCA2 Variants on Gene Expression After Radiation
Author Information
Author(s): Waddell Nic, Ten Haaf Anette, Marsh Anna, Johnson Julie, Walker Logan C., Gongora Milena, Brown Melissa, Grover Piyush, Girolami Mark, Grimmond Sean, Chenevix-Trench Georgia, Spurdle Amanda B.
Primary Institution: Queensland Institute of Medical Research
Hypothesis
Can gene expression profiles distinguish between BRCA1/2 mutation carriers and familial breast cancer cases without these mutations?
Conclusion
The study found that BRCA1 and BRCA2 variants of low clinical significance have gene expression profiles similar to pathogenic mutation carriers, suggesting they may confer a low to moderate risk of cancer.
Supporting Evidence
- BRCA1 and BRCA2 mutation carriers had similar expression profiles.
- BRCAX individuals with low clinical significance variants clustered with BRCA1/2 mutation carriers.
- Prediction accuracy for BRCA1/2 status decreased with inclusion of BRCAX samples carrying low clinical significance variants.
Takeaway
This study looked at how certain gene changes in breast cancer patients affect their gene activity after radiation, finding that some changes might still be risky.
Methodology
Gene expression profiles were analyzed from lymphoblastoid cell lines after exposure to ionizing radiation.
Potential Biases
Potential bias in classification of variants and sample selection.
Limitations
The study could not distinguish between BRCA1 and BRCA2 mutations effectively due to experimental conditions.
Participant Demographics
Participants included women from high-risk breast cancer families, with 23 BRCA1 carriers, 22 BRCA2 carriers, and 27 BRCAX individuals.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website